X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs BIOCON LTD - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA BIOCON LTD FULFORD INDIA/
BIOCON LTD
 
P/E (TTM) x 398.8 36.7 1,087.6% View Chart
P/BV x 6.2 4.9 127.5% View Chart
Dividend Yield % 0.1 1.5 5.6%  

Financials

 FULFORD INDIA   BIOCON LTD
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
BIOCON LTD
Mar-16
FULFORD INDIA/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs942496 190.0%   
Low Rs450397 113.5%   
Sales per share (Unadj.) Rs691.4174.3 396.7%  
Earnings per share (Unadj.) Rs11.544.8 25.6%  
Cash flow per share (Unadj.) Rs15.456.9 27.0%  
Dividends per share (Unadj.) Rs2.005.00 40.0%  
Dividend yield (eoy) %0.31.1 25.6%  
Book value per share (Unadj.) Rs380.0202.8 187.4%  
Shares outstanding (eoy) m3.90200.00 2.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.02.6 39.3%   
Avg P/E ratio x60.710.0 609.9%  
P/CF ratio (eoy) x45.37.8 578.2%  
Price / Book Value ratio x1.82.2 83.3%  
Dividend payout %17.411.2 156.4%   
Avg Mkt Cap Rs m2,71489,220 3.0%   
No. of employees `0000.44.4 10.1%   
Total wages/salary Rs m5056,363 7.9%   
Avg. sales/employee Rs Th6,073.07,894.5 76.9%   
Avg. wages/employee Rs Th1,137.41,441.2 78.9%   
Avg. net profit/employee Rs Th100.72,029.7 5.0%   
INCOME DATA
Net Sales Rs m2,69634,854 7.7%  
Other income Rs m125845 14.8%   
Total revenues Rs m2,82235,699 7.9%   
Gross profit Rs m-468,200 -0.6%  
Depreciation Rs m152,423 0.6%   
Interest Rs m10102 9.3%   
Profit before tax Rs m546,520 0.8%   
Minority Interest Rs m0-744 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m05,754 0.0%   
Tax Rs m102,569 0.4%   
Profit after tax Rs m458,961 0.5%  
Gross profit margin %-1.723.5 -7.3%  
Effective tax rate %17.739.4 44.9%   
Net profit margin %1.725.7 6.4%  
BALANCE SHEET DATA
Current assets Rs m1,73839,932 4.4%   
Current liabilities Rs m54516,276 3.3%   
Net working cap to sales %44.367.9 65.2%  
Current ratio x3.22.5 130.1%  
Inventory Days Days4854 90.5%  
Debtors Days Days486 5.0%  
Net fixed assets Rs m1239,101 0.0%   
Share capital Rs m391,000 3.9%   
"Free" reserves Rs m1,44338,591 3.7%   
Net worth Rs m1,48240,556 3.7%   
Long term debt Rs m020,724 0.0%   
Total assets Rs m2,07784,816 2.4%  
Interest coverage x6.764.9 10.3%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.30.4 316.0%   
Return on assets %2.610.7 24.4%  
Return on equity %3.022.1 13.7%  
Return on capital %4.319.0 22.7%  
Exports to sales %030.7 0.0%   
Imports to sales %24.520.4 119.9%   
Exports (fob) Rs mNA10,717 0.0%   
Imports (cif) Rs m6597,105 9.3%   
Fx inflow Rs m1711,789 0.1%   
Fx outflow Rs m6738,393 8.0%   
Net fx Rs m-6563,396 -19.3%   
CASH FLOW
From Operations Rs m905,264 1.7%  
From Investments Rs m105-9,540 -1.1%  
From Financial Activity Rs m-1410,867 -0.1%  
Net Cashflow Rs m1816,591 2.7%  

Share Holding

Indian Promoters % 0.0 40.4 -  
Foreign collaborators % 75.0 20.6 364.1%  
Indian inst/Mut Fund % 3.8 8.4 45.2%  
FIIs % 0.1 10.7 0.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 19.9 106.5%  
Shareholders   4,783 109,995 4.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   DR. REDDYS LAB  STERLING BIOTECH  ASTRAZENECA PHARMA  AUROBINDO PHARMA  IPCA LABS  

Compare FULFORD INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Biocon: Lower R&D Expenses Help Margin Expansion (Quarterly Results Update - Detailed)

Sep 19, 2016

Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 5-YR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS